# Gout

This is a subcategory of Analgesic Agents.

## Formulary

### Preferred

| Preferred                | Generic Name                                 |         Quantity          |        Time (Days)        |
| :----------------------- | :------------------------------------------- | :-----------------------: | :-----------------------: |
| Allopurinol <sup>QL</sup>    | Allopurinol Tab (all strengths)              |            204            |            102            |
| Colchicine Tab             | Colchicine Tab (all strengths)               | Determined pursuant to PA | Determined pursuant to PA |
| Colcrys <sup>PA QL</sup> | Colchicine Tab (all strengths) | Determined pursuant to PA | Determined pursuant to PA |
| Probenecid <sup>QL</sup>           | Probenecid Tab (all strengths)               |            408            |            102            |

### Non-Preferred

| Non-Preferred    | Generic Name                   |         Quantity          |        Time (Days)        |
| :--------------- | :----------------------------- | :-----------------------: | :-----------------------: |
| Mitigare <sup>BvG QL</sup> | Colchicine Cap (all strengths) | Determined pursuant to PA | Determined pursuant to PA | 
| Febuxostat | | | |
| Gloperba Susp <sup>QL</sup> | Colchicine Soln (all strengths) | Determined pursuant to PA                          | Determined pursuant to PA                          |
| Probenecid/Colchicine <sup>QL</sup> | Probenecid w/ Colchicine Tab (all strengths) | Determined pursuant to PA | Determined pursuant to PA |

## Length of Authorizations

365 Days

## Prior Authorization Criteria

Is there any reason the patient cannot be changed to an agent not requiring prior approval?

Acceptable reasons include:

- Allergy to medications not requiring prior approval

- Contraindication to or drug-to-drug interaction with medications not requiring prior approval.

- History of unacceptable/toxic side effects to medications not requiring prior approval

## Additional Criteria

The requested medication may be approved if the following is true:

- Febuxostat will be approved after 30-day trial of maximum allopurinol dose, or intolerance/contraindication to allopurinol.

- Colchicine tablets will be approved if any one of the following is true:

  - Diagnosis of Familial Mediterranean Fever (FMF) (180-day approval); OR

  - Trial of one of the following within the last 30 days:

    - NSAID (i.e., indomethacin, naproxen, ibuprofen, sulindac, ketoprofen)

    - Oral corticosteroid

- Colchicine capsules can be approved if the patient had a trial and failure with colchicine tablets

- Gloperba will be approved if the patient is unable to swallow colchicine tablets or capsules and if all of following are met:

  - Patient is using Gloperba for the prevention of gout flares

  - Trial of one of the following within the last 30 days:

    - NSAID (i.e., indomethacin, naproxen, ibuprofen, sulindac, ketoprofen)

    - Oral corticosteroid

\* Colchicine quantity limit 6/claim for acute gout, 60/30 days for chronic gout after trial on xanthine oxidase inhibitor, 120/30 days for FMF

\* Gloperba quantity limit is 1.2 mg per day

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=6)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=7)
